| [1] | Food and Drug Administration (2008) Guidance for industry: General principles for the development of vaccines to protect against global infectious diseases. Available: http://www.fda.gov/BiologicsBloodVaccine？s/GuidanceComplianceRegulatoryInformatio？n/Guidances/Vaccines/ucm074762.htm. Accessed 17 June 2009.
|
| [2] | LaForce FM, Konde K, Viviani S, Preziosi MP (2007) The Meningitis Vaccine Project. Vaccine 25: (Suppl 1)A97–A100.
|
| [3] | Bejon P, Lusingu J, Olotu A, Leach A, Lievens M, et al. (2008) Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age. N Engl J Med 359: 2521–2532.
|
| [4] | Skeiky YAW, Sadoff JC (2006) Advances in tuberculosis vaccine strategies. Nat Rev Microbiol 4: 469–476.
|
| [5] | Johnston MI, Fauci AS (2008) An HIV vaccine—Challenges and prospects. N Engl J Med 359: 888–890.
|
| [6] | Walker RI (2005) New vaccines against enteric bacteria for children in less developed countries. Expert Rev Vaccines 4: 807–812.
|
| [7] | Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Sachs SE (2007) Control of neglected tropical diseases. N Engl J Med 357: 1018–1027.
|
| [8] | Brennan MJ, Fruth U, Milstien J, Tiernan R, de Andrade Nishioka S, et al. (2007) Development of new tuberculosis vaccines: A global perspective on regulatory issues. PLoS Med 4: e252. doi:10.1371/journal.pmed.0040252.
|
| [9] | European Medicines Agency (2005) Guideline on procedural aspects regarding a CHMP scientific opinion in the context of cooperation with the World Health Organisation (WHO) for the evaluation of medicinal products intended exclusively for markets outside the community. Available: http://www.emea.europa.eu/pdfs/human/reg？affair/557904en.pdf. Accessed 17 June 2009.
|
| [10] | World Health Organization (2006) Procedures for assessing the acceptability of vaccines for purchase by United Nations agencies. Available: http://www.path.org/vaccineresources/fil？es/Procedures_acceptability_purchase_by_？UN.pdf. Accessed 17 June 2009.
|
| [11] | Milstien J, Dellepiane N, Lambert S, Belgharbi L, Rolls C, et al. (2002) Vaccine quality—Can a single standard be defined? Vaccine 2956: 1–4.
|
| [12] | [No authors listed] (1994) Recommendations of the Advisory Committee on Immunization Practices (ACIP): Typhoid immunization. MMWR 43: 1–7.
|
| [13] | [No authors listed] (1993) Recommendations of the Advisory Committee on Immunization Practices (ACIP): Inactivated Japanese encephalitis virus vaccine. MMWR 42: 1–15.
|
| [14] | Olin P, Rasmussen F, Gustafsson L, Hallander HO, Heijbel H (1997) Randomized controlled trial of two-component, three-component and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines. Lancet 350: 1569–1577.
|
| [15] | US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research (2008) Guidance for industry: Tropical disease priority review vouchers. Available: http://www.fda.gov/downloads/Drugs/Guida？nceComplianceRegulatoryInformation/Guida？nces/UCM080599.pdf. Accessed 23 June 2009.
|
